At a glance
- Originator Polifarma
- Class Antihypertensives; Peptides; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 11 Jun 2001 Discontinued-Preclinical for Hypertension in Italy (Unknown route)
- 04 Sep 1998 Suspended-Preclinical for Hypertension in Italy (Unknown route)